Literature DB >> 18301415

Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy.

Daniel M Patterson1, Anwar R Padhani, David J Collins.   

Abstract

Diffusion-weighted MRI (DW-MRI) is a functional imaging technique that displays information about the extent and direction of random water motion in tissues. Water movement in tissues is modified by interactions with hydrophobic cellular membranes, intracellular organelles and macromolecules. DW-MRI provides information on extracellular-space tortuosity, tissue cellularity and the integrity of cellular membranes. Images can be sensitive to large or small displacements of water, therefore, macroscopic water flows and microscopic water displacements in the extracellular space can be depicted. Preclinical and clinical data indicate a number of potential roles of DW-MRI in the characterization of malignancy, including determination of lesion aggressiveness and monitoring response to therapy. This Review outlines the biological basis of observations made on DW-MRI and describes how measurements are acquired and quantified, and discusses the interpretation of images and limitations of the technique. The strength of evidence for adoption of DW-MRI as a biomarker for the assessment of tumor response is presented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18301415     DOI: 10.1038/ncponc1073

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


  122 in total

Review 1.  Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging.

Authors:  Venkata S Katabathina; Nathalie Lassau; Ivan Pedrosa; Chaan S Ng; Srinivasa R Prasad
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

2.  Diffusion-prepared fast imaging with steady-state free precession (DP-FISP): a rapid diffusion MRI technique at 7 T.

Authors:  Lan Lu; Bernadette Erokwu; Gregory Lee; Vikas Gulani; Mark A Griswold; Katherine M Dell; Chris A Flask
Journal:  Magn Reson Med       Date:  2011-12-02       Impact factor: 4.668

3.  T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer.

Authors:  Ewelina Kluza; Esther D Rozeboom; Monique Maas; Milou Martens; Doenja M J Lambregts; Jos Slenter; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2012-07-10       Impact factor: 5.315

Review 4.  Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy.

Authors:  Anwar R Padhani; Aftab Alam Khan
Journal:  Target Oncol       Date:  2010-04-11       Impact factor: 4.493

5.  Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma.

Authors:  Vincent Vandecaveye; Piet Dirix; Frederik De Keyzer; Katya Op de Beeck; Vincent Vander Poorten; I Roebben; Sandra Nuyts; Robert Hermans
Journal:  Eur Radiol       Date:  2010-02-24       Impact factor: 5.315

6.  Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer.

Authors:  Huaijun Wang; Guy Marchal; Yicheng Ni
Journal:  World J Radiol       Date:  2011-01-28

7.  Investigation of the diffusion abnormality index as a new imaging biomarker for early assessment of brain tumor response to radiation therapy.

Authors:  Reza Farjam; Christina I Tsien; Felix Y Feng; Diana Gomez-Hassan; James A Hayman; Theodore S Lawrence; Yue Cao
Journal:  Neuro Oncol       Date:  2013-12-09       Impact factor: 12.300

8.  Multimodal imaging for early functional response assessment of (90)Y-/ (177)Lu-DOTATOC peptide receptor targeted radiotherapy with DW-MRI and (68)Ga-DOTATOC-PET/CT.

Authors:  Sarah Wulfert; Clemens Kratochwil; Peter L Choyke; Ali Afshar-Oromieh; Walter Mier; Hans-Ulrich Kauczor; Jens-Peter Schenk; Uwe Haberkorn; Frederik L Giesel
Journal:  Mol Imaging Biol       Date:  2014-08       Impact factor: 3.488

Review 9.  Pitfalls of diffusion-weighted imaging of the female pelvis.

Authors:  Ana Luisa Duarte; João Lopes Dias; Teresa Margarida Cunha
Journal:  Radiol Bras       Date:  2018 Jan-Feb

10.  Serial diffusion MRI to monitor and model treatment response of the targeted nanotherapy CRLX101.

Authors:  Thomas S C Ng; David Wert; Hargun Sohi; Daniel Procissi; David Colcher; Andrew A Raubitschek; Russell E Jacobs
Journal:  Clin Cancer Res       Date:  2013-03-26       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.